Impact of insulin therapy before donation on graft outcomes in pancreas transplantation: An analysis of the OPTN/UNOS database
Enrique Montagud‐Marrahí(Hospital Clínic de Barcelona), Pedro Ventura‐Aguiar(Hospital Clínic de Barcelona), Enric Esmatjes, Joana Ferrer(Instituto de Salud Carlos III), F Oppenheimer(Hospital Clínic de Barcelona), Frederic Cofán(Hospital Clínic de Barcelona), Núria Esforzado(Hospital Clínic de Barcelona), Fritz Diekmann(Hospital Clínic de Barcelona), Alícia Molina‐Andújar(Hospital Clínic de Barcelona), Josep M. Campistol(Universitat de Barcelona), David Cucchiari(European Association of Urology), Mireía Musquera(Surgical Specialties (Canada)), Beatriu Bayés(Hospital Clínic de Barcelona), Antonio J. Amor(Hospital Clínic de Barcelona), Ignacio Revuelta(Hospital Clínic de Barcelona), Vicens Torregrosa(Hospital Clínic de Barcelona), Joaquim Casals(Hospital Clínic de Barcelona), María José Ramírez-Bajo(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 1
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
|Gastroenterology|2013|597
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566
In Vivo Activation of a Conserved MicroRNA Program Induces Mammalian Heart Regeneration
|Cell stem cell|2014|201